ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma

Zhang, Lishuo; Di, Longjiang; Liu, Jinhui; Lei, Xianli; Gu, Maoli; Zhang, Wenjing*; Wang, Yufu*南方医科大学; 哈尔滨医科大学; 1
Frontiers in Genetics2023-1-23DOI: 10.3389/fgene.2023.1039813
15阅读
引用收藏
分享

摘要

Cuproptosis is a new form of cell death, the second form of metal ion-induced cell death defined after ferroptosis. Recently, cuproptosis has been suggested to be associated with tumorigenesis. However, the relationship between cuproptosis and patient prognosis in clear cell renal cell carcinoma (ccRCC) in the context of immunotherapy remains unknown. The aim of this study was to investigate the correlation between cuproptosis-related long non-coding RNA (lncRNA) and ccRCC in terms of immunity as well as prognosis. Clinical information on lncRNAs associated with differences in cuproptosis genes in ccRCC and normal tissues was collected from The Cancer Genome Atlas (TCGA) dataset. Univariate Cox regression was used to screen lncRNAs. A total of 11 lncRNAs closely associated with cuproptosis were further screened and established using the least absolute shrinkage and selection operator (LASSO) algorithm and multivariate Cox regression, and the samples were randomly divided into training and test groups. A risk prognostic model was constructed using the training group, and the model was validated using the test group. We investigated the predictive ability of the prognostic risk model in terms of clinical prognosis, tumor mutation, immune escape, immunotherapy, tumor microenvironment, immune infiltration levels, and tumor drug treatment of ccRCC. Using the median risk score, patients were divided into low and high-risk groups. Kaplan-Meier curves showed that the overall survival (OS) of patients in the high-risk group was significantly worse than low-risk group (p < 0.001). Receiver operating characteristic (ROC) curves further validated the reliability of our model. The model consistently and accurately predicted prognosis at 1, 3, and 5 years, with an AUC above 0.7. Tumor cell genes generally precede morphological abnormalities; therefore, the model we constructed can effectively compensate for the traditional method of evaluating the prognosis of patients with renal cancer, and our model was also clinically meaningful in predicting ccRCC staging. In addition, lower model risk scores determined by mutational load indicated a good chance of survival. The high-risk group had greater recruitment of immune cells, while the anti-immune checkpoint immunotherapy was less efficacious overall than that of the low-risk group. Tumor and immune-related pathways were enriched, and anti-tumor agents were selected to improve the survival of ccRCC. This prognostic risk model is based on the levels of cuproptosis-associated lncRNAs and provides a new perspective in the clinical assessment and precise treatment of ccRCC.

学科与关键词

关键词
clear cell renal cell carcinomalong non-coding RNAcuproptosisprognosisimmunotherapy
相关
加载中…
  • A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma
    Yu, Sheng; Tang, Lingxue; Zhang, Qianqian; Li, Wen; Yao, Senbang; Cai, Yinlian; Cheng, Huaidong*HEREDITAS, 2023, 160(1): 31.被引 2
  • A Novel Immune-Related lncRNA-Based Model for Survival Prediction in Clear Cell Renal Cell Carcinoma
    Zhang, Zedan; Tang, Yanlin; Liu, Yanjun; Zhuang, Hongkai; Lin, Enyu; Xie, Lu; Feng, Xiaoqiang; Tian, Kaiwen; Zeng, Jiayi; Liu, Jiumin; Yu, Yuming*Journal of Immunology Research, 2021, 2021: 9921466.被引 10
  • Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients
    Jiang, Zi-Rong; Yang, Lin-Hui; Jin, Liang-Zi; Yi, Li-Mu; Bing, Ping-Ping; Zhou, Jun*; Yang, Jia-Sheng*Frontiers in Oncology, 2022, 12: 988680.被引 25
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Genetics
发表日期
2023-01-23
卷期
第 14 卷
页码
1039813
DOI
10.3389/fgene.2023.1039813
成果收录
SCIE
资助标注
Financial asistance under Heilongjiang Postdoctoral Fund [LBH-Z18121]; National Natural Science Foundation of China [82001715]; Health and Family Planning Commission of Heilongjiang Provincial [2018286]; Fundamental Research Funds for the Provincial Universities [2017LCZX67]

作者

  • Z

    Zhang, Lishuo (第一作者)

    1 · harbin med univ

  • D

    Di, Longjiang

    southern med univ

查看全部 7 位作者收起作者
  • L

    Liu, Jinhui

    2 · harbin med univ

  • L

    Lei, Xianli

    harbin med univ

  • G

    Gu, Maoli

    1 · harbin med univ

  • Z

    Zhang, Wenjing (通讯)

    2 · harbin med univ

  • W

    Wang, Yufu (通讯)

    2 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417